LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Guardant Health Inc

Closed

SectorHealthcare

38.03 3.09

Overview

Share price change

24h

Current

Min

36.18

Max

38.19

Key metrics

By Trading Economics

Income

16M

-95M

Sales

1.7M

203M

EPS

-0.49

Profit margin

-46.768

Employees

1,999

EBITDA

-12M

-111M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+61.94% upside

Dividends

By Dow Jones

Next Earnings

6 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-938M

5B

Previous open

34.94

Previous close

38.03

News Sentiment

By Acuity

29%

71%

72 / 382 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Guardant Health Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 May 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

23 May 2025, 21:57 UTC

Hot Stocks

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23 May 2025, 21:15 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 May 2025, 21:04 UTC

Acquisitions, Mergers, Takeovers

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23 May 2025, 20:56 UTC

Top News
Acquisitions, Mergers, Takeovers

Salesforce Back in Deal Talks With Informatica -- WSJ

23 May 2025, 20:51 UTC

Top News

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23 May 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23 May 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 May 2025, 20:41 UTC

Top News

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23 May 2025, 20:28 UTC

Top News

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23 May 2025, 20:06 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23 May 2025, 20:06 UTC

Acquisitions, Mergers, Takeovers

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23 May 2025, 19:50 UTC

Top News

Trump's Tariffs: Where Things Stand -- 16th Update

23 May 2025, 19:28 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23 May 2025, 19:28 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23 May 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23 May 2025, 19:20 UTC

Market Talk

Crude Futures Post Modest Weekly Losses -- Market Talk

23 May 2025, 19:18 UTC

Market Talk

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23 May 2025, 18:57 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 May 2025, 18:54 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23 May 2025, 18:53 UTC

Top News
Acquisitions, Mergers, Takeovers

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23 May 2025, 18:52 UTC

Acquisitions, Mergers, Takeovers

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23 May 2025, 18:13 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23 May 2025, 18:13 UTC

Market Talk

Gold Trades Higher on Reminder of Risk -- Market Talk

23 May 2025, 18:00 UTC

Top News

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23 May 2025, 17:51 UTC

Market Talk
Earnings

Workday Sees Higher Bar for Guidance -- Market Talk

23 May 2025, 17:42 UTC

Top News

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

23 May 2025, 17:39 UTC

Market Talk

U.S. Oil Rig Count Falls to Lowest Level Since November 2021 -- Market Talk

23 May 2025, 17:07 UTC

Top News

Trump's Tariffs: Where Things Stand -- 15th Update

23 May 2025, 17:04 UTC

Market Talk
Earnings

Workday Appears to Have Upside Potential on Conservative Outlook -- Market Talk

Peer Comparison

Price change

Guardant Health Inc Forecast

Price Target

By TipRanks

61.94% upside

12 Months Forecast

Average 60 USD  61.94%

High 70 USD

Low 52 USD

Based on 19 Wall Street analysts offering 12 month price targets forGuardant Health Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

19

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

38.86 / 47.41Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

72 / 382 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.